{"podcast":{"title":"DOC Updates","slug":"doc-updates-200053","podcast_index_feed_id":200053,"rss_url":"https://diabetescoreupdate.libsyn.com/rss","website_url":"http://diabetescoreupdate.libsyn.com","image_url":"https://static.libsyn.com/p/assets/7/5/1/2/751262fede9556bed959afa2a1bf1c87/Podcasts_DOC_Updates_Final_teal_1400x1400.jpg","author":"American Diabetes Association","episode_count":100,"summary":"DOC Updates is a monthly podcast that presents and discusses the latest clinically relevant articles in the field of diabetes research and care, including the American Diabetes Association's three science and health journals – Diabetes, Diabetes Care, and Diabetes, Obesity, and Cardiometabolic CARE. Each episode is approximately 15 minutes long and presents 5-6 recently published articles from ADA journals and beyond. Intended for practicing physicians and health care professionals, DOC Updates discusses how the latest research and information published in journals of the American Diabetes Association and beyond are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Clinical Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency…","last_synced_at":"2026-09-25T04:18:08.178503+00:00","page_url":"https://stenobird.com/podcast/doc-updates-200053"},"episode":{"title":"Impact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more!","slug":"impact-of-finerenone-on-albuminuria-in-t1d-national-trends-in-out-of-pocket-cost-for-glucose-lowering-drugs-and-more","published_at":"2026-08-10T14:00:00+00:00","page_url":"https://stenobird.com/podcast/doc-updates-200053/impact-of-finerenone-on-albuminuria-in-t1d-national-trends-in-out-of-pocket-cost-for-glucose-lowering-drugs-and-more","show_page_url":"https://stenobird.com/podcast/doc-updates-200053","url":"https://diabetescoreupdate.libsyn.com/impact-of-finerenone-on-albuminuria-in-t1d-national-trends-in-out-of-pocket-cost-for-glucose-lowering-drugs-and-more","audio_url":"https://traffic.libsyn.com/secure/diabetescoreupdate/Diabetes-Core-Update-August-2026.mp3?dest-id=159994","summary":"Welcome to the latest episode (August 2026) of DOC Updates , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates : Hirsh Elhence, Jennifer L. Dodge, Stephen Fuest, et al. National Prevalence of Clinical Obesity by BMI Class: A National Cross-Sectional Study . Ann Intern Med. [Epub 2 June 2026]. doi: 10.7326/ANNALS-25-05287 Eva Johnsen, et al. Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study . Diabetes Care 20 July 2026; 49 (8): 1480–1489. doi.org/10.2337/dc26-0937 Carel W. le Roux, et al. Survodutide Once Weekly for the Treatment of Adults with Obesity . The New England Journal of Medicine June 2026 DOI: 10.1056/NEJMoa2600751 Yu Wang, Shichao Tang, Xilin Zhou, Ping Zhang. National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs Among U.S. Adults With Diabetes, 2000–2022 . Diabetes Care 20 July 2026; 49 (8): 1414–1419. https://doi.org/10.2337/dc25-2040 Jelle M. Beernink, et al. Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial . Diabetes Care 20 July 2026; 49 (8): 1434–1441. https://doi.org/10.2337/dc26-0882 Welch M, Forst T, Jia W et al. Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial . The Lancet, 2026; 408, 125-140 DOI: 10.1016/S0140-6736(26)00800-7 Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jeffers…","meta_description":"Welcome to the latest episode (August 2026) of DOC Updates , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1939,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/impact-of-finerenone-on-albuminuria-in-t1d-national-trends-in-out-of-pocket-cost-for-glucose-lowering-drugs-and-more/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/doc-updates-200053/impact-of-finerenone-on-albuminuria-in-t1d-national-trends-in-out-of-pocket-cost-for-glucose-lowering-drugs-and-more.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}